Skip to main content

IDBS Expands US Headquarters to Include Healthcare Center of Excellence


This week, IDBS expanded its office in Burlington, Mass., to include a Healthcare Center of Excellence to support its efforts on the translational medicine front.

The center is expected to support IDBS' personalized medicine activities through collaborations with the local and international health science ecosystem, the company said.

The company opened a US-based headquarters for its healthcare business last July and added 22 full-time employees to better serve its customers in the space.

At the time, IDBS' Founder and CEO Neil Kipling said that the Burlington office was "a natural US hub" for company pursuits in the translational medicine market, and that the concentration of clinical research efforts, life sciences research and development, and industrial-academic collaborations provided "an ideal environment to expand our R&D business and to create our US Center of Excellence for Healthcare."

The company has existing relationships with the Dana-Farber Cancer Institute, Selventa, Merck, Biogen, Shire, and Novartis, among other life sciences groups that are located in the region.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.